This free sheet contains 100 accelerators and incubators you can apply to today, along with information about the industries they generally invest in.
This free sheet contains all the information about the top 100 unicorns, including their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
This free Notion document contains the best 100+ resources you need for building a successful startup, divided in 4 categories: Fundraising, People, Product, and Growth.
The pharmaceutical sector includes 19 unicorn companies transforming healthcare. Among them, healthtech platform Judi Health has reached a valuation of $3.25 billion.
Biomanufacturing firm Resilience has secured $3.4 billion in funding to support its operations.
Below is the full list of 19 Pharmaceutical unicorn startups at this time.
Everything you need to raise funding for your startup, including 3,500+ investors, 7 tools, 18 templates and 3 learning resources.
Buy It For $97 $297 →Information about the industries, countries, and cities they generally invest in.
Get the Sheet for $50Information about their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
Get the Sheet for $50List of startup investors in the BioTech, Health, and Medicine industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50List of 250 startup investors in the AI and Machine Learning industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50List of 250 startup investors in the FinTech and Finance industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50Judi Health provides a pharmacy benefit management (PBM) platform designed to navigate the complexities of prescription drug pricing. Their full-service solution uses a modern technology stack to help employers, unions, and government groups reduce costs and improve member care.
Insitro is developing a new approach to drug discovery by combining machine learning with the creation of vast biological datasets. Their platform generates predictive models from this data to identify new therapeutic targets and design more effective drugs.
Medable created a platform that powers decentralized clinical trials and predictive medicine. It relies on patient-generated data to help researchers accelerate the process of bringing new treatments to people who need them.
ConcertAI builds AI-powered SaaS and data solutions for advancing oncology research. Their platform analyzes real-world evidence to help researchers and pharmaceutical companies accelerate clinical trials and bring new cancer therapies to patients.
Blink Health created a healthcare platform to make prescription drugs more affordable and accessible for everyone. They offer transparent pricing and home delivery, connecting patients directly with lower costs on their medications.
Orna Therapeutics is building a new class of medicine based on its fully engineered circular RNA (oRNA) platform. These novel therapeutics are designed to treat a broad range of illnesses, including cancer and genetic diseases.
L&P Cosmetic develops science-backed skincare products under its globally recognized brand, Mediheal. They are best known for their popular line of affordable sheet masks, which are developed in collaboration with dermatologists and skincare experts.
Insilico Medicine created Pharma.AI, an end-to-end generative AI platform for discovering and developing new drugs. They use the platform to build their own pipeline of therapeutics, becoming one of the first to move an AI-discovered drug into human clinical trials.
Resilience partners with biopharmaceutical companies to manufacture complex medicines, including cell and gene therapies. Their network of manufacturing sites is designed to strengthen supply chains and broaden access to novel treatments.
Enveda Biosciences develops novel medications by exploring the chemistry of the natural world. Their drug discovery platform uses machine learning to identify new therapeutic compounds from plants.
The ten most valuable companies are just part of a much larger picture. Together, the remaining unicorns have raised over $3 billion, with founders building these businesses everywhere from the United States to China and India.
Some are just getting started, while others have been around for over a decade. Here’s a look at the other pharmaceutical startups that have reached the billion dollar mark.
| Unicorn Startup | Country | Year Founded | Amount Raised | Valuation |
|---|---|---|---|---|
| United States | 2016 | $192M | $1B | |
| United States | 2016 | $570M | $1B | |
| Singapore | 2024 | $188M | $1B | |
| United States | 2016 | $304.1M | $1B | |
| United States | 2015 | $50.6M | $1B | |
| United States | 2013 | $528M | $1B | |
| China | 2011 | $317.6M | $1B | |
| China | 2000 | $682M | $1B | |
| India | 2015 | $230.8M | $1B |
